BusinessOtonomy Announces Plan to Focus Resources on Development ProgramsBy Nasdaq OMXNov 27, 2017, 9:30 PM UTC
BusinessOtonomy Announces Publication of OTIPRIO™ Phase 3 Clinical Trial Results in JAMA OtolaryngologyBy Nasdaq OMXMar 18, 2016, 11:30 AM UTC